Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00337766
Status:
COMPLETED
Last Update Posted:
2015-10-21
First Post:
2006-06-15
Brief Title:
Desmopressin in Cardiac Surgery
Sponsor:
Università Vita-Salute San Raffaele
Organization:
Università Vita-Salute San Raffaele
Study Overview
Official Title:
Efficacy of Desmopressin 1-deamin0-8-D-arginine-vasopressin in Reducing Active Microvascular Bleeding After Cardiac Surgery
Status:
COMPLETED
Status Verified Date:
2013-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients undergoing cardiac surgery could develop excessive perioperative bleeding requiring transfusions of blood products
Desmopressin DDAVP already used for patients with von Willebrand syndrome could reduce bleeding and transfusion requirements in these patients when administered ev 03 mgkg in 20-30 minutes postoperatively
Desmopressin DDAVP already used for patients with von Willebrand syndrome could reduce bleeding and transfusion requirements in these patients when administered ev 03 mgkg in 20-30 minutes postoperatively
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None